Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, CHEMED CORPORATION reported revenue of $2.53B, up 4.1% year over year. Operating margin was 13.4% and net margin 10.5%, on a free-cash-flow margin of 12.9% with capital expenditure at 2.5% of revenue. Every figure is computed directly from CHE's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $2.53B | 13.4% | 10.5% |
| FY2024 | $2.43B | 15.1% | 12.4% |
| FY2023 | $2.26B | 15.0% | 12.0% |
| FY2022 | $2.13B | 16.1% | 11.7% |
| FY2021 | $2.14B | 16.0% | 12.6% |
How does CHE compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AACG · ABSI · ACCS · ACHC · ACM · ADUS
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.